MedTrace Logo

hCG Priming in Women With Low Ovarian Reserve

NCT04643925 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-08-25

No results posted yet for this study

Summary

The aim of this trial is to examine the possible effects of hCG administration for eight weeks prior to IVF/ICSI in women with low ovarian reserve. Primary outcome is the proportion of the antral follicle count that reach the pre-ovulatory stage.

Conditions

  • Infertility, Female
  • Ovarian Reserve
  • In Vitro Fertilization

Interventions

DRUG

Ovitrelle

Ovitrelle 260 IE once daily for 8 weeks prior to IVF/ICSI

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Anja B Pinborg, MD · The Fertility Department, Rigshospitalet

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-27
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04643925 on ClinicalTrials.gov